Sanara MedTech Inc. SMTI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $458.6K+128% | -$1.61M+94.7% | -$30.41M-1,407% | -$2.02M+42.8% | -$3.53M-107% | ||
| $587.25K-12.1% | $668.4K-35.7% | $1.04M-6.8% | $1.11M-0.9% | $1.12M-30.1% | ||
| $1.03M-13.0% | $1.18M-4.1% | $1.23M-14.1% | $1.44M+10.0% | $1.3M+9.1% | ||
| —— | $1.84M— | —— | —— | -$9.67K— | ||
| $75K+50.0% | $50K-69.7% | $165.2K+43.7% | $115K-35.8% | $179.03K-54.5% | ||
| $1.71M— | —— | $270.05K— | —— | -$368.28K-121% | ||
| -$765.15K-217% | $655.27K— | $0-100% | $525.15K-13.3% | $605.63K+774% | ||
| -$1.43M-222% | $1.17M+470% | -$317.5K+50.3% | -$638.3K-207% | $595.84K— | ||
| -$166.16K— | —— | -$394.55K-462% | $109.04K+433% | -$32.76K-105% | ||
| $81.78K+3.4% | $79.09K-8.6% | $86.53K+1.0% | $85.7K-68.7% | $274.06K+13.7% | ||
| -$462.51K-42.4% | -$324.73K-12.5% | -$288.64K-47.7% | -$195.48K-36.1% | -$143.61K-145% | ||
| -$83.23K-3.4% | -$80.53K+5.1% | -$84.86K-1.7% | -$83.43K+70.0% | -$278.08K-11.0% | ||
| -$2.47M-162% | $3.95M+81.3% | $2.18M-18.3% | $2.66M+233% | -$2M— | ||
| $43.77K-46.7% | $82.16K-92.2% | $1.06M-39.8% | $1.76M+2.2% | $1.72M+2,287% | ||
| —— | —— | —— | —— | $60K— | ||
| —— | $2.36M+0.1% | $2.36M+11,138% | $21.01K-99.4% | $3.52M+10,133% | ||
| -$43.77K+98.2% | -$2.45M+28.5% | -$3.42M+12.9% | -$3.93M+24.2% | -$5.18M-3,885% | ||
| —— | —— | —— | —— | $12.07M— | ||
| -$397.22K— | —— | -$71.75K— | —— | —— | ||
| -$475.22K-441% | $139.43K— | —— | —— | $11.99M— | ||
| -$2.98M-282% | $1.64M+181% | -$2.02M— | —— | $4.81M— | ||
| $1.52M+64.2% | $923.73K+1.3% | $911.5K+2.4% | $889.78K+42.0% | $626.78K-0.9% | ||
| $143— | —— | —— | —— | $52.98K+422% | ||
| $27.11K-3.7% | $28.16K-15.9% | $33.48K-22.0% | $42.91K-1.6% | $43.63K-1.6% | ||
| —— | —— | —— | —— | —— | ||
| $73.54K0.0% | $73.54K0.0% | $73.54K0.0% | $73.54K+24.1% | $59.28K0.0% | ||
| —— | $1.84M— | —— | —— | -$9.67K— | ||
| $181.94K-9.7% | $201.41K0.0% | $201.41K0.0% | $201.41K+14.4% | $176.08K+27.2% | ||
| -$462.51K-42.4% | -$324.73K-12.5% | -$288.64K-47.7% | -$195.48K-36.1% | -$143.61K-145% | ||
| $15.85K+778% | -$2.34K+53.4% | -$5.02K+46.9% | -$9.45K-187% | $10.89K+109% | ||
| —— | $0+100% | -$9.08K+73.1% | -$33.74K-1,597% | $2.25K— | ||
| -$3.12M-1,356% | $248.35K-89.9% | $2.46M+23.8% | $1.99M+177% | -$2.57M-202% | ||
| -$105.44K— | —— | $86.69K-65.3% | $249.85K+272% | $67.22K-79.3% | ||
| -$83.23K-3.4% | -$80.53K+5.1% | -$84.86K-1.7% | -$83.43K+70.0% | -$278.08K-11.0% | ||
| -$166.16K— | —— | -$394.55K-462% | $109.04K+433% | -$32.76K-105% | ||
| $62.8K-32.1% | $92.47K-21.4% | $117.62K-31.9% | $172.68K-13.3% | $199.28K+20.4% | ||
| —— | $606.2K+1.3% | $598.17K+2.4% | $583.92K+42.0% | $411.32K-0.9% | ||
| $75K+50.0% | $50K-69.7% | $165.2K+43.7% | $115K-35.8% | $179.03K-54.5% | ||
| —— | $2.36M+0.1% | $2.36M+11,138% | $21.01K-99.4% | $3.52M+10,133% | ||
| —— | —— | —— | —— | $60K— | ||
| $78K0.0% | $78K-88.9% | $703K+801% | $78K0.0% | $78K-93.3% | ||
| -$397.22K— | —— | -$71.75K— | —— | —— | ||
| —— | —— | —— | —— | $12.07M— | ||
| —— | —— | —— | —— | $1.1M— | ||
| -$83.23K-3.4% | -$80.53K+5.1% | -$84.86K-1.7% | -$83.43K+70.0% | -$278.08K-11.0% | ||
| —— | —— | —— | —— | $2.08M— | ||
| $143— | —— | —— | —— | $52.98K+422% | ||
| -$2.51M-165% | $3.86M— | —— | —— | -$3.72M— | ||
| -$2.51M-165% | $3.86M— | —— | —— | -$3.72M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sanara MedTech Inc. generate?
- Sanara MedTech Inc. (SMTI) generated $6.3M in operating cash flow over the trailing twelve months.
- What is Sanara MedTech Inc.'s free cash flow?
- After $2.9M of capital expenditures, Sanara MedTech Inc.'s free cash flow was -$3.8M over the trailing twelve months, up 36.7% year over year.
- Where does Sanara MedTech Inc.'s cash flow data come from?
- Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
